These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Albuminuria in kidney transplant recipients is associated with increased urinary serine proteases and activation of the epithelial sodium channel. Hinrichs GR, Michelsen JS, Zachar R, Friis UG, Svenningsen P, Birn H, Bistrup C, Jensen BL. Am J Physiol Renal Physiol; 2018 Jul 01; 315(1):F151-F160. PubMed ID: 29363322 [Abstract] [Full Text] [Related]
4. Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy. Andersen H, Hansen PB, Bistrup C, Nielsen F, Henriksen JE, Jensen BL. J Hypertens; 2016 Aug 01; 34(8):1621-9. PubMed ID: 27214087 [Abstract] [Full Text] [Related]
5. Urinary serine proteases and activation of ENaC in kidney--implications for physiological renal salt handling and hypertensive disorders with albuminuria. Svenningsen P, Andersen H, Nielsen LH, Jensen BL. Pflugers Arch; 2015 Mar 01; 467(3):531-42. PubMed ID: 25482671 [Abstract] [Full Text] [Related]
6. Prostasin-dependent activation of epithelial Na+ channels by low plasmin concentrations. Svenningsen P, Uhrenholt TR, Palarasah Y, Skjødt K, Jensen BL, Skøtt O. Am J Physiol Regul Integr Comp Physiol; 2009 Dec 01; 297(6):R1733-41. PubMed ID: 19793956 [Abstract] [Full Text] [Related]
7. Plasmin in urine from patients with type 2 diabetes and treatment-resistant hypertension activates ENaC in vitro. Buhl KB, Oxlund CS, Friis UG, Svenningsen P, Bistrup C, Jacobsen IA, Jensen BL. J Hypertens; 2014 Aug 01; 32(8):1672-7; discussion 1677. PubMed ID: 24805959 [Abstract] [Full Text] [Related]
8. Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice. Hinrichs GR, Weyer K, Friis UG, Svenningsen P, Lund IK, Nielsen R, Mollet G, Antignac C, Bistrup C, Jensen BL, Birn H. Acta Physiol (Oxf); 2019 Dec 01; 227(4):e13362. PubMed ID: 31423748 [Abstract] [Full Text] [Related]
9. Remission of nephrotic syndrome diminishes urinary plasmin content and abolishes activation of ENaC. Andersen RF, Buhl KB, Jensen BL, Svenningsen P, Friis UG, Jespersen B, Rittig S. Pediatr Nephrol; 2013 Aug 01; 28(8):1227-34. PubMed ID: 23503750 [Abstract] [Full Text] [Related]